Search Videos and More
News
Director of Simmons Cancer Center, UTSW Pharmacology Chair elected to the National Academy of Medicine
Carlos L. Arteaga, M.D., and David Mangelsdorf, Ph.D., are UTSW’s 23rd and 24th members of the NAM, the most of any institution in Texas
News
Latino enclaves in U.S. have less accessible health care
Study led by UTSW researcher describes socioeconomic challenges in culturally distinct neighborhoods for fastest-growing ethnic group
News
UT Southwestern biochemist Zhijian ‘James’ Chen, Ph.D., earns prestigious Lasker Award
Dr. Chen’s discovery of cGAS, which triggers innate immunity, also honored with Germany’s top scientific prize
News
Pathway tied to cancer-driving genome alterations identified
Understanding how chromosome shattering occurs could lead to strategies to overcome therapy resistance, UTSW study shows
News
Widespread disparities exist in treating advanced cancers
Likelihood of patients receiving FDA-approved immunotherapies for late-stage kidney and bladder cancers linked to race, socioeconomic factors, facility type
News
Basic Research: R01s – Drs. Todd Aguilera & You Zhang
Doctor Spotlights
News
DARTBOARD Clinical Trial
DARTBOARD (STU2021-0401: A Prospective Randomized Phase II Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer), an innovative, first-of-its-kind clinical trial, is now complete.
News
Markerless Radiation Erases a Reminder and Improves Breast Cancer Therapy
Breast cancer almost always leaves its mark on patients. Along with surgical scars and changes in breast size and shape, medical tattoos or semi-permanent marker dots and lines were drawn on the patient’s chest to align radiotherapy beams, like checkpoints on a map.
News
Upon Further RefleXion
The RefleXion X1 radiation treatment platform is the first to integrate PET/CT imaging with a medical linear accelerator. Using a PET signal identifying the tumor while also depicting its biology, RefleXion treats patients with unique biology-guided radiotherapy (BgRT). The UT Southwestern Department of Radiation Oncology is one of a handful of centers worldwide with this treatment capability.
News
Upgrading HDR Brachytherapy
High-dose-rate (HDR) brachytherapy is a procedure where the patient receives a dose from a powerful radioactive source for a few minutes per treatment session, after which the source is removed. The radioactive source, stored in an afterloader unit, travels through special applicators that then deliver the dose to the site of the tumor.
News
A Beacon of Hope in the Fight Against Pancreatic Cancer
Our Pancreatic Cancer Program’s vision is to build a future where all patients have improved survival, are empowered to overcome adversity, achieve the highest quality of life, and are fully supported to thrive alongside their providers.
News
New AI tool to detect possible metastatic breast cancer
By improving MRI sensitivity, a model developed by UT Southwestern could potentially eliminate unnecessary biopsies